Spectrum Pharmaceuticalsincis A Biopharmaceutical Company Based In Hendersonnevadafocused On Developing And Commercializing Innovative Therapies For Oncology And Hematologythe Company Operates Research And Development Facilities In Massachusetts And California And Has A Presence In The U S Europejapanand Other Markets The Company Is Dedicated To Addressing Unmet Medical Needs In Cancer Treatmentparticularly Through Targeted Therapies And Supportive Care Productsspectrum Has Conducted Over 120 Clinical Trials To Advance Its Product Pipelinewhich Includes Fda Approved Therapies Such As Rolvedonkhapzoryand Rolontisit Also Has Poziotiniban Irreversible Tyrosine Kinase Inhibitor For Non Small Cell Lung Cancerin Phase 2 Trialsspectrum Pharmaceuticals Engages In Full Cycle Drug Developmentfrom Clinical Trials To Commercializationand Utilizes Sales Intelligence Tools To Support Market Analysis
